<SEC-DOCUMENT>0001193125-21-168704-index.html : 20210521 <SEC-HEADER>0001193125-21-168704.hdr.sgml : 20210521 <ACCEPTANCE-DATETIME>20210521093030 ACCESSION NUMBER: 0001193125-21-168704 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20210521 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210521 DATE AS OF CHANGE: 20210521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Larimar Therapeutics, Inc. CENTRAL INDEX KEY: 0001374690 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203857670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36510 FILM NUMBER: 21946823 BUSINESS ADDRESS: STREET 1: THREE BALA PLAZA EAST. SUITE 506 CITY: BALA CYNWYD STATE: PA ZIP: 19004 BUSINESS PHONE: 844-511-9056 MAIL ADDRESS: STREET 1: THREE BALA PLAZA EAST. SUITE 506 CITY: BALA CYNWYD STATE: PA ZIP: 19004 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN, INC. DATE OF NAME CHANGE: 20100301 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN INC DATE OF NAME CHANGE: 20060906 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>d188842d8k.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: d188842d8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>2 <FILENAME>d188842dex41.htm <DESCRIPTION>EX-4.1 <TEXT> Document 2 - file: d188842dex41.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>3 <FILENAME>d188842dex101.htm <DESCRIPTION>EX-10.1 <TEXT> Document 3 - file: d188842dex101.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>4 <FILENAME>d188842dex102.htm <DESCRIPTION>EX-10.2 <TEXT> Document 4 - file: d188842dex102.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.3 <SEQUENCE>5 <FILENAME>d188842dex103.htm <DESCRIPTION>EX-10.3 <TEXT> Document 5 - file: d188842dex103.htm
</DOCUMENT> </SEC-DOCUMENT>